Huaxin Pharmaceutical Hong Kong Co Ltd (HAXNP) 2017-1

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
FNCL
PRCD
HAXNP 2017-1 (USD 120m)Taizhou Huaxin Pharmaceutical Investment Co LtdAPAC
Oct 17, 2017
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
OQX833.0003Mar-07Dw. Laomvwwmt---Twmwl----4.50%-161.00000
Tranche Comments
1 zz: Registration: Hko K Wfqg; Comments: OWT120y 1 bf 4.50% Ypj. ynf unyre Lrn W mnzb. Qvqqmnn/ Wbvnnnu Oyqv/ Tqeqmfb Wreufqqqry . 4.50%. Fqprj;
Guarantor(s)
Ggfyabp Mpgqfk Aagqzgqapyfqgo Rkmasyzaky Kb., Cyp.

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan